{"output": [["Nohla Therapeutics Inc.", "COMP", "Appoint", "James Johnson", "PERSON"], ["James Johnson", "PERSON", "Operate_In", "Nohla Therapeutics Inc.", "COMP"], ["Nohla Therapeutics Inc.", "COMP", "Has", "Lead clinical programs", "CONCEPT"], ["NanoString Technologies", "COMP", "Past_Job", "James Johnson", "PERSON"], ["Relypsa Inc.", "COMP", "Past_Job", "James Johnson", "PERSON"], ["ZymoGenetics Inc.", "COMP", "Past_Job", "James Johnson", "PERSON"], ["AmpliPhi", "COMP", "Past_Job", "James Johnson", "PERSON"], ["Immunex Corporation", "COMP", "Past_Job", "James Johnson", "PERSON"], ["Nohla Therapeutics Inc.", "COMP", "Has", "Strong financial backing", "CONCEPT"], ["Nohla Therapeutics Inc.", "COMP", "Has", "Innovative technology platform", "CONCEPT"], ["Nohla Therapeutics Inc.", "COMP", "Has", "Experienced and committed management team", "CONCEPT"], ["Nohla Therapeutics", "COMP", "Produce", "Cell therapy products", "PRODUCT"], ["Cell therapy products", "PRODUCT", "Address", "Significant unmet medical need", "CONCEPT"], ["Nohla Therapeutics", "COMP", "Has", "Leading investors", "COMP"], ["Nohla Therapeutics", "COMP", "Has", "Nohla101", "PRODUCT"], ["Nohla101", "PRODUCT", "Provides", "Functional support of bone marrow", "CONCEPT"], ["Nohla101", "PRODUCT", "Overcome", "Broad safety and logistical risks", "CONCEPT"], ["Nohla101", "PRODUCT", "Demonstrate", "Potential for robust efficacy", "CONCEPT"], ["Nohla Therapeutics", "COMP", "Has", "Website", "COMP"], ["Nohla Therapeutics", "COMP", "Has", "Twitter account", "COMP"], ["Nohla Therapeutics", "COMP", "Has", "Senior Director, Corporate Development & Investor Relations", "CONCEPT"], ["Senior Director, Corporate Development & Investor Relations", "CONCEPT", "Has", "Phone number", "CONCEPT"], ["Senior Director, Corporate Development & Investor Relations", "CONCEPT", "Has", "Email address", "CONCEPT"], ["Nohla Therapeutics", "COMP", "Source", "Press release", "CONCEPT"]], "published": "2018-01-05T00:00:00.000+02:00"}